International Journal for Vitamin and Nutrition Research · 2011 · 20 citations · 13 references
Life SciencesGeneticsMolecular GeneticsCardiovascular GeneticsHuman GeneticsMedical GeneticsCardiovascular DiseaseFolate DeficiencyGenetic RiskHypertension PreventionRiboflavin DeficiencyVitamin BiochemistryBlood PressureBlood Pressure GeneticsCardiovascular Risk ModulationGenetic Determinants Of HypertensionHomocysteine ElevationMethylenetetrahydrofolate Reductase PolymorphismsRiboflavin FortificationVitamin B2 (Riboflavin)
Hypertension is a leading risk factor for cardiovascular disease (CVD) and stroke. A common polymorphism in the gene encoding the enzyme methylenetetrahydrofolate reductase (MTHFR), previously identified as the main genetic determinant of elevated homocysteine concentration and also recognized as a risk factor for CVD, appears to be independently associated with hypertension. The B-vitamin riboflavin is required as a cofactor by MTHFR and recent evidence suggests it may have a role in modulating blood pressure, specifically in those with the homozygous mutant MTHFR 677 TT genotype. If studies confirm that this genetic predisposition to hypertension is correctable by low-dose riboflavin, the findings could have important implications for the management of hypertension given that the frequency of this polymorphism ranges from 3 to 32 % worldwide.
13
Evidence for a Gene Influencing Blood Pressure on Chromosome 17
Daniel Levy, Anita L. DeStefano, Martin G. Larson et al. · Hypertension · 2000 · 596 citations · Full text
Bridget Wilcken · Journal of Medical Genetics · 2003 · 460 citations · Full text